All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or Myeloma crowd.
Philippe Armand and Roch Houot share information related to the recently launched COVID-HEME initiative including how hematologists can get involved.
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to improve and accelerate the knowledge and experience of physicians to optimize the management of patients during the pandemic.
To join COVID-HEME, please ask for an invitation at email@example.com
COVID-HEME forum supports hematologists during COVID-19 pandemic
Your opinion matters
EHA 2019 | GEM-CESAR shows promise for smoldering MM: KRd + HDT-ASCT therapy
Results of the GEM-CESAR phase II clinical trial. This study assessed the curative potential of carfilzomib, lenalidomide, and dexamethasone combination in patients with...
The impact of pre-existing monoclonal gammopathy on patient outcome in newly diagnosed multiple myeloma
Gaurav Goyal from the Division of Hematology, Mayo Clinic, and his team utilized their institution’s data from 1973 to 2015 to ascertain the...
Subscribe to get the best content related to multiple myeloma delivered to your inbox